CorrlensCorrlens
Correlate

Correlation Analysis

Broadcom Inc. Common Stock vs Regeneron Pharmaceuticals Inc

AVGO vs REGN

+0.037

Near-zero positive

When one moves up, the other tends to follow.

AVGO logo

Broadcom Inc. Common Stock

AVGO

Broadcom is one of the largest semiconductor companies in the world and has also expanded into infrastructure software. Its semiconductors primarily serve computing and networking, with custom AI accelerators now accounting for the bulk of the business. It is primarily a fabless designer, but holds some manufacturing in-house, such as for its best-of-breed film bulk acoustic resonator filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments. Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as VMware, Brocade, CA Technologies, and Symantec in software.

Market cap 1.5T

REGN logo

Regeneron Pharmaceuticals Inc

REGN

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

Market cap 80.7B · 15,410 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 observationsStockStockTechnologyHealthcare

Time Series

Rebased to 100

Green: AVGOGray: REGN36 of 1,254 points (sampled)

Who Moves First

in sync

AVGO and REGN tend to move at the same time.

Best correlation after shifting: +0.037 (13 shifts scanned)

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

-0.502

14 periods · Return correlation when both series rose

Both Falling

N/A

4 periods · Return correlation when both series fell

Diverging

-0.825

17 periods · Return correlation when series moved apart

R-Squared

0.1%

Share of variance in one series explained by the other.

Trend Agreement

56.6%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

n.s.

95% CI: [-0.019, 0.092]

Scatter

XY Regression

201002003004004034226008001,0001,198Broadcom Inc. Common StockRegeneron Pharmaceuticals IncData pointsFit (r = 0.037)

Pipeline

Data quality details

Pipeline Summary

1,254 paired observations survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

AVGO logo

Broadcom Inc. Common Stock

AVGO

Market cap 1.5T

Stock · 1,254 raw → 1,254 prepared

Series B

REGN logo

Regeneron Pharmaceuticals Inc

REGN

Market cap 80.7B · 15,410 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

26

Estimated crossover points between normalized spreads.

Slope

0.0572

Linear regression slope.

Intercept

725.9638

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 3 hours ago · ID: stock-avgo-vs-stock-regn-daily-20260408-3c255n